These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2512447

  • 21. Ganglioside-composition of brain in Tay-Sachs disease: increased amounts of GD2 and N-acetyl-beta-D-galactosaminyl GD1a ganglioside.
    Iwamori M, Nagai Y.
    J Neurochem; 1979 Mar; 32(3):767-77. PubMed ID: 430057
    [No Abstract] [Full Text] [Related]

  • 22. Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model.
    Martino S, Cavalieri C, Emiliani C, Dolcetta D, Cusella De Angelis MG, Chigorno V, Severini GM, Sandhoff K, Bordignon C, Sonnino S, Orlacchio A.
    Neurochem Res; 2002 Aug; 27(7-8):793-800. PubMed ID: 12374215
    [Abstract] [Full Text] [Related]

  • 23. GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosis.
    Raghavan S, Krusell A, Lyerla TA, Bremer EG, Kolodny EH.
    Biochim Biophys Acta; 1985 Apr 25; 834(2):238-48. PubMed ID: 3995063
    [Abstract] [Full Text] [Related]

  • 24. GM2 ganglioside and pyramidal neuron dendritogenesis.
    Walkley SU, Siegel DA, Dobrenis K.
    Neurochem Res; 1995 Nov 25; 20(11):1287-99. PubMed ID: 8786814
    [Abstract] [Full Text] [Related]

  • 25. Morphology of the gangliosidoses.
    Goebel HH.
    Neuropediatrics; 1984 Sep 25; 15 Suppl():97-106. PubMed ID: 6100800
    [Abstract] [Full Text] [Related]

  • 26. Prenatal diagnosis of GM2-gangliosidosis B1 variant.
    Lemos M, Pinto R, Ribeiro G, Ribeiro H, Lopes L, Sá Miranda MC.
    Prenat Diagn; 1995 Jun 25; 15(6):585-8. PubMed ID: 7659693
    [Abstract] [Full Text] [Related]

  • 27. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 28. Periodate oxidation of glycolipids: a borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections.
    Buk SJ, High OB.
    Histochem J; 1986 May 15; 18(5):228-32. PubMed ID: 3091539
    [Abstract] [Full Text] [Related]

  • 29. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D, Higashine Y, Matsuoka K, Sakuraba H, Itoh K.
    Clin Chim Acta; 2007 Mar 15; 378(1-2):38-41. PubMed ID: 17196574
    [Abstract] [Full Text] [Related]

  • 30. 31Phosphorus magnetic resonance spectroscopy in late-onset Tay-Sachs disease.
    Felderhoff-Mueser U, Sperner J, Konstanzcak P, Navon R, Weschke B.
    J Child Neurol; 2001 May 15; 16(5):377-80. PubMed ID: 11392526
    [Abstract] [Full Text] [Related]

  • 31. Fundus autofluorescence in Tay-Sachs disease.
    Abalem MF, Francischini S, Carricondo PC, Graziano RM.
    JAMA Ophthalmol; 2014 Jul 15; 132(7):876. PubMed ID: 24852271
    [No Abstract] [Full Text] [Related]

  • 32. Clinical course of GM2 gangliosidoses. A correlative attempt.
    Schulte FJ.
    Neuropediatrics; 1984 Sep 15; 15 Suppl():66-70. PubMed ID: 6100797
    [Abstract] [Full Text] [Related]

  • 33. Retinal amacrine cell involvement in Tay-Sachs disease.
    Nagashima K, Kikuchi F, Suzuki Y, Abe T.
    Acta Neuropathol; 1981 Sep 15; 53(4):333-6. PubMed ID: 7223376
    [Abstract] [Full Text] [Related]

  • 34. Brain gangliosides: an improved simple method for their extraction and identification.
    Randell JA, Pennock CA.
    J Chromatogr; 1980 Jul 18; 195(2):257-64. PubMed ID: 6773970
    [Abstract] [Full Text] [Related]

  • 35. Proton MR spectroscopy in three children with Tay-Sachs disease.
    Aydin K, Bakir B, Tatli B, Terzibasioglu E, Ozmen M.
    Pediatr Radiol; 2005 Nov 18; 35(11):1081-5. PubMed ID: 16079982
    [Abstract] [Full Text] [Related]

  • 36. Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.
    Kobayashi T, Goto I, Okada S, Orii T, Ohno K, Nakano T.
    J Neurochem; 1992 Oct 18; 59(4):1452-8. PubMed ID: 1402895
    [Abstract] [Full Text] [Related]

  • 37. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
    Phaneuf D, Wakamatsu N, Huang JQ, Borowski A, Peterson AC, Fortunato SR, Ritter G, Igdoura SA, Morales CR, Benoit G, Akerman BR, Leclerc D, Hanai N, Marth JD, Trasler JM, Gravel RA.
    Hum Mol Genet; 1996 Jan 18; 5(1):1-14. PubMed ID: 8789434
    [Abstract] [Full Text] [Related]

  • 38. Tay-Sachs disease with conspicuous cranial computerized tomographic appearances.
    Watanabe K, Mukawa A, Muto K, Nishikawa J, Takahashi S.
    Acta Pathol Jpn; 1985 Nov 18; 35(6):1521-32. PubMed ID: 2936060
    [Abstract] [Full Text] [Related]

  • 39. Spinal ganglia and peripheral nerves from a patent with Tay-Sachs disease. Morphological and ganglioside studies.
    Abe T, Ogawa K, Fuziwara H, Urayama K, Nagashima K.
    Acta Neuropathol; 1985 Nov 18; 66(3):239-44. PubMed ID: 2990149
    [Abstract] [Full Text] [Related]

  • 40. Regulation of GM2 ganglioside metabolism in cultured cells.
    Dawson G, Hancock LW, Vartanian T.
    Chem Phys Lipids; 1986 Dec 15; 42(1-3):105-16. PubMed ID: 3549015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.